Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Conjugate Vaccine GSK1024850A

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: July 3, 2007
Last updated: October 11, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2009
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 20, 2009